"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

133 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic.

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study

NCT04285801

COVID-19

COMPLETED

Clinical Features of COVID-19 Patients

NCT04815304

Covid19 Acute Respiratory Distress Syndrome Ventilatory Failure

COMPLETED

Clinical Features of Severe Patients With COVID-19

NCT04450017

SARS-CoV2

COMPLETED

Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19

NCT04388670

COVID-19 Critical Illness

UNKNOWN

Comparing Metabolic Characteristics of Persistent Critically Ill Non-COVID and COVID-19 Patients

NCT05026151

Persistent Critical Illness

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Material \& Methods:

Study design: Retrospective study. Study Settings: Study was conducted in Fatima Memorial Hospital, Lahore. Study Duration: Study was conducted on Covid-19 patients who were admitted from March 2021 to August 2021.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with COVID-19 pneumonia

These patients were admitted in ICU for management of Covid-19 pneumonia usual care was offered to all patients

Patients with COVID-19 Pneumonia

Intervention Type COMBINATION_PRODUCT

Patients were offered with usual care of COVID-19 in ICU and we did retrospective study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients with COVID-19 Pneumonia

Patients were offered with usual care of COVID-19 in ICU and we did retrospective study

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Critically sick patients with COVID-19 Pneumonia
* All admitted ICU patients with a diagnosis of COVID-19 pneumonia
* Patients having positive reverse transcriptase PCR for COVID-19
* Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury
* All patients above 16 years of age with both genders( males and females)